Baicalin, a metabolite of baicalein with antiviral activity against dengue virus

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Moghaddam, Ehsan ^a   Teoh, Boon Teong ^a   Sam, Sing Sin ^a   Lani, Rafidah ^a   Hassandarvish, Pouya ^a   Chik, Zamri ^a   Yueh, Andrew ^b   Abubakar, Sazaly ^a   Zandi, Keivan ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BAICALEIN; BAICALIN; FLAVANONE DERIVATIVE; FLAVONOID;

ANIMAL; CELL SURVIVAL; CHLOROCEBUS AETHIOPS; DENGUE VIRUS; DOSE RESPONSE; DRUG EFFECTS; HUMAN; LD50; METABOLISM; PHYSIOLOGY; VERO CELL LINE; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; DENGUE VIRUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVANONES; FLAVONOIDS; HUMANS; LETHAL DOSE 50; VERO CELLS; VIRUS REPLICATION;

EID: 84903291470     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05452     Document Type: Article

References (32)

1. Hidari, K. I. et al. Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga. Biochem. Biophys. Res. Commun 376, 91-95 (2008).
2. Talarico, L. B. & Damonte, E. B. Interference in dengue virus adsorption and uncoating by carrageenans. Virology 363, 473-485 (2007). (Pubitemid 46766683)
3. Zandi, K. et al. Flavone enhances dengue virus type-2 (NGC strain) infectivity and replication in Vero cells. Molecules 17, 2437-2445 (2012a).
4. Huh, S. U. & Paek, K. H. Plant RNA binding proteins for control of RNA virus infection. Front Physiol 4, 397 (2013).
5. Kumar, S. & Pandey, A. K. Chemistry and Biological Activities of Flavonoids: An Overview. Scientific World Journal 29, 2013:1650 (2013).
6. Lyu, S. Y., Rhim, J. Y. & Park, W. B. Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro. Arch. Pharm. Res 28, 1293-301 (2005).
7. Evers, D. L. et al. Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action. Antiviral Res. 68, 124-134 (2005). (Pubitemid 41612456)
8. Beecher, G. R. Overview of dietary flavonoids: nomenclature, occurrence and intake. J. Nutr 133, 3248-3254 (2003).
9. Zandi, K. et al. Novel antiviral activity of baicalein against dengue virus. BMC Complement Altern Med 12, 1-9 (2012b).
10. Zandi, K. et al. Antiviral activity of four types of bioflavonoid against dengue virus type-2. Virol. J 8, 560 (2011).
11. Ozcelik, B., Orhan, I. & Toker, G. Antiviral and antimicrobial assessment of some selected flavonoids. Z. Naturforsch. C. Biosci 61, 632 (2006).
12. Tian, S. et al. Pharmacokinetic study of baicalein after oral administration in monkeys. Fitoterapia 83, 532-540 (2012).
13. Tian, S. et al. Pharmacokinetic study of baicalein and its major metabolites after iv administration in dogs. CHM 3, 196-201 (2011).
14. Che, Q. et al. Studies on metabolites of baicalin in human urine. Zhongguo Zhong Yao Za Zahi 26, 768 (2001).
15. Xu, G., Dou, J., Zhang, L., Guo, Q. & Zhou, C. Inhibitory effects of baicalein on the influenza virus in vivo is determined by baicalin in the serum. Biol. Pharm. Bul 33, 238-243 (2010).
16. Lai, M. Y., Hsiu, S. L., Chen, C. C., Hou, Y. C. & Chao, P. D. L. Urinary pharmacokinetics of baicalein, wogonin and their glycosides after oral administration of Scutellariae Radix in humans. Biol. Pharm. Bull 26, 79-83 (2013).
17. Dou, J. et al. Effects of baicalein on Sendai virus in vivo are linked to serum baicalin and its inhibition of hemagglutinin-neuraminidase. Arch. Virol 156, 793-801 (2011).
18. Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504-507 (2013).
19. Lim, S. P. et al. Ten years of dengue drug discovery: progress and prospects. Antiviral Res. 100, 500-19 (2013).
20. Koishi, A. C., Zanello, P. R., Bianco, É, M., Bordignon, J. & Nunes Duarte dos Santos, C. Screening of dengue virus antiviral activity of marine seaweeds by an In Situ Enzyme-Linked Immunosorbent Assay. PLoS one 7, e51089 (2012).
21. Michel, T., Halabalaki, M. & Skaltsounis, A. L. New concepts, experimental approaches, and dereplication strategies for the discovery of novel phytoestrogens from natural sources. Planta Med 79, 514-32 (2013).
22. Romano, B. et al. Novel insights into the pharmacology of flavonoids. Phytother Res 27, 1588-96 (2013).
23. Cushnie, T. P. & Lamb, A. J. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents 26, 343-56 (2005). (Pubitemid 41483464)
24. Zandi, K. et al. Extract of Scutellaria baicalensis inhibits dengue virus replication. BMC Complement Altern Med 13, 91(2013).
25. Guo, X. Y. et al. Identification of the metabolites of baicalein in human plasma. J Asian Nat Prod Res 13, 861-868 (2011).
26. Chen, S. et al. Effects of the flavonoid baicalin and its metabolite baicalein on androgen receptor expression, cell cycle progression and apoptosis of prostate cancer cell lines. Cell Prolif 34, 293-304 (2001). (Pubitemid 32939476)
27. Xin, W. et al. Research progress on pharmacological actions and mechanism of baicalein and baicalin. Curr Opin Complement Alternat Med 1, e00010 (2014).
28. Yang, C. C. et al. Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus. Antiviral Res. 98, 228-41(2013).
29. Wong, S. S., Abd-Jamil, J. & Abubakar, S. Antibody neutralization and viral virulence in recurring dengue virus type 2 outbreaks. Viral Immunol 20, 359-368 (2007).
30. Wong, P. F. & Abubakar, S. High intracellular Zn21ions modulate the VHR, ZAP-70 and ERK activities of LNCaP prostate cancer cells. Cell. Mol. Biol. Lett 13, 375-390 (2008).
31. Seah, C. L. K., Chow, V. T. K., Tan, H. C. & Can, Y. C. Rapid, single-step RT-PCR typing of dengue viruses using five NS3 gene primers. J. Virol. Methods 51, 193-200 (1995).
32. Laille, M., Gerald, F. & Debitus, C. In vitro antiviral activity on dengue virus of marine natural products. Cell. Mol. Life. Sci. 54, 167-70 (1998). (Pubitemid 28134863)